Pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa
US11844860B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2019 |
| Grant date | Dec 19, 2023 |
| Priority date | — |
| Expiry date | Jul 10, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa as active ingredients and one or more excipients. Once dispersed in an aqueous medium, melevodopa is completely dissolved, and carbidopa is present as nanoparticles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.